Author: Zacks Small Cap Research

123456630 / 658 POSTS
By David Bautz, PhDNASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Phase 3 ALS Trial is Fully Enrolled On October 10, 2019, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) announced that the Phase 3 clinical trial of NurOwn® in patien ...
By Brian Marckx, CFANASDAQ:MTBC READ THE FULL MTBC RESEARCH REPORT Q3 2019 Results: MTBC, Inc (NASDAQ:MTBC) reported financial results for their third quarter 2019 and provided a business update. Revenue was down 1% yoy, up 1% qoq and about 6% bette ...
NASDAQ:SNES (Source: Shutterstock) Leptospira is a bacterium that is transmitted by rats to humans. As per CDC, contracting Leptospirosis can cause illness and when left untreated can lead to respiratory distress, kidney damage, liver failure and de ...
By Lisa ThompsonNASDAQ:ABDC READ THE FULL ABDC RESEARCH REPORT Alcentra Capital (NASDAQ:ABDC) reported it Q3 2019, which we expect is its last quarter as a public company. It is in the process of being purchased by Crescent Capital BDC for $11.02 per ...
By David Bautz, PhDOTC:CHEXF READ THE FULL CHEXF RESEARCH REPORT We are initiating coverage of Avivagen, Inc. (OTC:CHEXF) with a valuation of $2.50. Avivagen is developing products to support animal health, which includes replacing antibiotics in liv ...
By Lisa ThompsonNASDAQ:NETE READ THE FULL NETE RESEARCH REPORT Net Element (NASDAQ:NETE) has been fine tuning its business over the past year, focusing on more profitable business and working to eliminate the cash burn and turn it to a positive to av ...
By David Bautz, PhD NASDAQ:CFRXREAD THE FULL CFRX RESEARCH REPORTBusiness Update Phase 3 Clinical Trial to Initiate in 4Q19 On October 2, 2019, ContraFect Corp. (NASDAQ:CFRX) announced that following a successful ‘end-of-Phase 2’ meeting with the FDA ...
By David Bautz, PhDNASDAQ:SPHS READ THE FULL SPHS RESEARCH REPORT Business Update Sophiris Bio Inc. (NASDAQ:SPHS) is developing treatments for localized clinically significant prostate cancer and lower urinary tract symptoms of benign prostatic hyper ...
By Lisa ThompsonNASDAQ:CSSE READ THE FULL CSSE RESEARCH REPORT Mirroring its new original content show Going From Broke, Chicken Soup for the Soul Entertainment (NASDAQ:CSSE) has given Crackle a financial makeover and is on the cusp of bring an entit ...
By David Bautz, PhDNASDAQ:CBMG READ THE FULL CBMG RESEARCH REPORT Business Update Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) is a biopharmaceutical company developing cell-based therapies for cancer and degenerative diseases. The company is curre ...
123456630 / 658 POSTS